Delayed
Japan Exchange
02:00:00 2024-05-16 EDT
5-day change
1st Jan Change
2,532
JPY
-0.76%
+15.64%
-4.92%
Final dividend
Final dividend
H.U. Group Cuts Forecasts for Fiscal Year Ended March 31
05-01
MT
H.U. Group Holdings, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
04-26
CI
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Executive Officer
04-26
CI
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer
04-26
CI
H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field
03-13
MT
Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics
03-12
CI
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems
12-22
CI
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook
12-22
MT
H.U. Group to Issue Stock Options to Directors, Employees
12-21
MT
H.U. Group to Grant Share Options to Staff
11-19
MT
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024
11-09
CI
H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index
23-09-18
CI
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47%
23-05-17
MT
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024
23-05-16
CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024
23-05-16
CI
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
23-05-12
CI
H.U. Group Holdings, Inc. Announces Launch of the Fully Automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests
23-03-28
CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023
23-02-10
CI
H.U. Group Holdings, Inc. Provides Year End Dividend Forecast for the Fiscal Year Ending March 31, 2023
23-02-10
CI
H.U. Group Holdings, Inc. Provides Dividend Guidance for the Second Quarter-End and for the Full Year of Fiscal Year Ending March 31, 2023
22-08-15
CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023
22-08-15
CI
Japan Equities End Week Higher; W-Scope Zooms 12% on Securing Approval for Unit's Listing in Korea
22-06-24
MT
H.U. Group Unit to Acquire Biomarker Assays Developer for $42 million
22-06-24
MT
H.U. Group Holdings, Inc. Provides Dividend Guidance for the Fiscal Year Ended March 31, 2022
22-05-20
CI
H.U. Group Unit Designates Managing Director
22-04-25
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
More about the company
Last Close Price
2,552
JPY
Average target price
2,422
JPY
Spread / Average Target
-5.09%
Consensus
1st Jan change
Capi.
-4.92% 937M -15.71% 8.57B +67.50% 4.3B -9.81% 2.47B -3.42% 2.46B -42.54% 2.31B -6.49% 1.93B -20.45% 1.53B -41.24% 1.2B +10.26% 1.14B
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**